Zebra Technologies (ZBRA)
(Delayed Data from NSDQ)
$399.31 USD
+2.13 (0.54%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $399.29 -0.02 (-0.01%) 7:58 PM ET
1-Strong Buy of 5 1
F Value B Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$399.31 USD
+2.13 (0.54%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $399.29 -0.02 (-0.01%) 7:58 PM ET
1-Strong Buy of 5 1
F Value B Growth A Momentum C VGM
Zacks News
Ingersoll Rand (IR) to Post Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Ingersoll Rand's (IR) second-quarter 2022 earnings are likely to have benefited from its acquired assets. However, supply-chain challenges might have hurt its performance.
Can Zebra Technologies (ZBRA) Retain Beat Steak in Q2 Earnings?
by Zacks Equity Research
Robust demand for both task management and prescriptive analytics software solutions is likely to have aided Zebra Technologies' (ZBRA) Q2 earnings, partly offset by supply-chain and cost woes.
Illinois Tool (ITW) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Illinois Tool's (ITW) second-quarter 2022 earnings are likely to have gained from its acquired assets. However, supply-chain challenges might have hurt performance.
Will Supply Chain & Cost Woes Mar Xylem's (XYL) Q2 Earnings?
by Zacks Equity Research
While supply chain restrictions and raw material cost inflation are likely to have hurt Xylem's (XYL) Q2 performance, solid backlog level and effective pricing is expected to have aided the same.
Will Cost Headwinds Dampen A.O. Smith's (AOS) Q2 Earnings?
by Zacks Equity Research
While an impressive performance in the North America segment is expected to have aided A.O. Smith's (AOS) Q2 performance, high costs might have impeded its bottom line.
Stanley Black (SWK) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Stanley Black's (SWK) Q2 performance is likely to have benefited from strength across end markets and synergies from acquired assets, partly offset by supply-chain woes and inflationary pressure.
Allegion (ALLE) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Gains from non-residential businesses are likely to have aided Allegion's (ALLE) Q2 performance amid adversities from labor shortages, material and freight-related cost inflation.
Will Supply Chain Woes Mar Honeywell's (HON) Q2 Earnings?
by Zacks Equity Research
While supply chain woes are likely to have hurt Honeywell's (HON) Q2 earnings, solid demand across the Aerospace and Building Technologies segments is expected to have aided the top line.
Fortune Brands (FBHS) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Fortune Brands' (FBHS) Q2 performance is likely to have benefited from higher revenues across all its segments, partly offset by supply-chain woes and inflationary pressure.
IDEX (IEX) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
While supply chain woes and escalating costs might have hurt IDEX's (IEX) Q2 earnings, pricing actions are expected to have partly offset the adversity.
General Electric (GE) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
General Electric's (GE) Q2 performance is likely to have benefited from higher revenues at the Healthcare and Aviation segments, partly offset by supply-chain woes and inflationary pressure.
What's in the Cards for Carlisle (CSL) This Earnings Season?
by Zacks Equity Research
While strong segmental performances are likely to have driven Carlisle's (CSL) Q2 earnings, supply chain constraints, inflation in raw material prices and labor challenges might have hurt the same.
Crane (CR) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
While impressive segmental performances are expected to have aided Crane's (CR) Q2 performance, high costs might have impeded its bottom line.
Will 3M's (MMM) Q2 Earnings Disappoint on Cost Headwinds?
by Zacks Equity Research
3M's (MMM) Q2 performance is likely to have been hurt by raw material and logistics cost inflation, as well as supply chain disruptions.
Will Cost Headwinds Dampen Danaher's (DHR) Q2 Earnings?
by Zacks Equity Research
While impressive segmental performances are expected to have aided Danaher's (DHR) Q2 performance, high costs might have impeded the bottom line.
Will Raw Material Cost Inflation Mar Alcoa's (AA) Q2 Earnings?
by Zacks Equity Research
Higher raw material and energy costs might have hurt Alcoa's (AA) Q2 performance. However, increased shipments and pricing are likely to have aided the same.
Cintas (CTAS) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Cintas' (CTAS) fiscal Q4 results are likely to reflect strength in its first aid cabinet service and uniform direct sale businesses. High cost and expenses might have dragged its performance.
Why Zebra (ZBRA) Could Beat Earnings Estimates Again
by Zacks Equity Research
Zebra (ZBRA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
InterDigital (IDCC) Inks Patent License Agreement With Zebra
by Zacks Equity Research
The multi-year non-exclusive royalty-bearing licensing deal with Zebra will likely generate incremental revenues for InterDigital (IDCC) in the long run.
Zebra Technologies (ZBRA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Zebra Technologies (ZBRA) closed the most recent trading day at $299.34, moving +1.83% from the previous trading session.
Zebra (ZBRA) Benefits From End Markets, Hurt by Cost Woes
by Zacks Equity Research
Zebra (ZBRA) is poised to benefit from its exposure in the diverse end markets, acquired assets and shareholder-friendly policies. However, cost woes and supply-chain disturbances remain a concern.
Zebra Technologies (ZBRA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Zebra Technologies (ZBRA) closed at $288.46 in the latest trading session, marking a -1.25% move from the prior day.
Zebra Technologies (ZBRA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Zebra Technologies (ZBRA) closed at $330.74 in the latest trading session, marking a -1.42% move from the prior day.
Zebra (ZBRA) Buys Matrox Imaging, Boosts Product Offerings
by Zacks Equity Research
Zebra's (ZBRA) acquisition of Matrox Imaging will enable it to provide a comprehensive line of automation and vision technology solutions to its customers.
Reasons Why You Should Avoid Investing in Zebra (ZBRA) Now
by Zacks Equity Research
Zebra (ZBRA) experiences weakness across its printing end market and bears high costs and operating expenses coupled with a heavy debt level.